Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Letters|August 27, 2013
Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cellsSonja Schiffer, Soriba Letzian, Edgar Jost, et al.Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.International Journal of Cancer|June 5, 2015
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemiaRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.Oncotarget|August 27, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivoRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.Pageof 2